Cargando…

Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma

Detalles Bibliográficos
Autores principales:	Evers, Marietheres, Schreder, Martin, Stühmer, Thorsten, Jundt, Franziska, Ebert, Regina, Hartmann, Tanja Nicole, Altenbuchinger, Michael, Rudelius, Martina, Kuric, Martin, Rindt, Wyonna Darleen, Steinbrunn, Torsten, Langer, Christian, Heredia-Guerrero, Sofia Catalina, Einsele, Hermann, Bargou, Ralf Christian, Rosenwald, Andreas, Leich, Ellen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036560/ https://www.ncbi.nlm.nih.gov/pubmed/36959208 http://dx.doi.org/10.1038/s41408-023-00817-7

Ejemplares similares

Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma
por: Leich, Ellen, et al.
Publicado: (2021)

Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines
por: Weißbach, Susann, et al.
Publicado: (2020)

Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma
por: Keppler, Sarah, et al.
Publicado: (2016)

Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules
por: Leich, E, et al.
Publicado: (2013)

Efficient Transient Transfection of Human Multiple Myeloma Cells by Electroporation – An Appraisal
por: Steinbrunn, Torsten, et al.
Publicado: (2014)

RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS
por: Seibold, Marcel, et al.
Publicado: (2019)

Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation
por: Effenberger, Madlen, et al.
Publicado: (2017)

The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1(+) subgroup of multiple myeloma cells for TNF-induced cell death
por: El-Mesery, Mohamed, et al.
Publicado: (2019)

Loss of Serum and Glucocorticoid-Regulated Kinase 3 (SGK3) Does Not Affect Proliferation and Survival of Multiple Myeloma Cell Lines
por: Hausmann, Stefan, et al.
Publicado: (2015)

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab
por: Einsele, Hermann, et al.
Publicado: (2016)

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma
por: Solimando, A G, et al.
Publicado: (2018)

Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
por: Rudelius, Martina, et al.
Publicado: (2018)

(11)C-Methionine-PET in Multiple Myeloma: Correlation with Clinical Parameters and Bone Marrow Involvement
por: Lapa, Constantin, et al.
Publicado: (2016)

TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms
por: Rauert, H, et al.
Publicado: (2011)

Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival
por: Maichl, Daniela Simone, et al.
Publicado: (2023)

Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature
por: Danhof, Sophia, et al.
Publicado: (2015)

Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns
por: Danhof, Sophia, et al.
Publicado: (2021)

Assessment of TP53 lesions for p53 system functionality and drug resistance in multiple myeloma using an isogenic cell line model
por: Munawar, Umair, et al.
Publicado: (2019)

First case of human peritoneal cysticercosis mimicking peritoneal carcinosis: necessity of laparoscopy and histologic assessment for the correct diagnosis
por: Rudelius, Martina, et al.
Publicado: (2017)

CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphoma
por: Rauert-Wunderlich, Hilka, et al.
Publicado: (2018)

The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NFκB Transcription Factors
por: Rauert-Wunderlich, Hilka, et al.
Publicado: (2013)

Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models
por: Kunz, Viktoria, et al.
Publicado: (2020)

Single Nucleotide Polymorphism Array Profiling of Adrenocortical Tumors - Evidence for an Adenoma Carcinoma Sequence?
por: Ronchi, Cristina L., et al.
Publicado: (2013)

A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors
por: Fink, Severin, et al.
Publicado: (2018)

NOTCH Signaling Is Activated through Mechanical Strain in Human Bone Marrow-Derived Mesenchymal Stromal Cells
por: Ziouti, Fani, et al.
Publicado: (2019)

Eosinophils and Megakaryocytes Support the Early Growth of Murine MOPC315 Myeloma Cells in Their Bone Marrow Niches
por: Wong, David, et al.
Publicado: (2014)

The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring “Multiple Myelomas”
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement
por: Steinhardt, Maximilian J., et al.
Publicado: (2021)

Assessing Osteolytic Lesion Size on Sequential CT Scans Is a Reliable Study Endpoint for Bone Remineralization in Newly Diagnosed Multiple Myeloma
por: Grunz, Jan-Peter, et al.
Publicado: (2023)

Tumor cell-selective apoptosis induction through targeting of K(V)10.1 via bifunctional TRAIL antibody
por: Hartung, Franziska, et al.
Publicado: (2011)

Molecular biocoding of insulin
por: Kurić, Lutvo
Publicado: (2010)

Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2
por: Horn, Heike, et al.
Publicado: (2018)

Interactions between Muscle and Bone—Where Physics Meets Biology
por: Herrmann, Marietta, et al.
Publicado: (2020)

Non-Invasive Bioluminescence Imaging to Monitor the Immunological Control of a Plasmablastic Lymphoma-Like B Cell Neoplasia after Hematopoietic Cell Transplantation
por: Chopra, Martin, et al.
Publicado: (2013)

[(68)Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [(18)F]FDG and laboratory values
por: Lapa, Constantin, et al.
Publicado: (2017)

Exploration of Artificial Intelligence Use with ARIES in Multiple Myeloma Research
por: Loda, Sophia, et al.
Publicado: (2019)

Optimization of trans-Splicing for Huntington's Disease RNA Therapy
por: Rindt, Hansjörg, et al.
Publicado: (2017)

Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis
por: Benkert, Thomas F., et al.
Publicado: (2012)

Dynamics of major histocompatibility complex class II-positive cells in the postischemic brain - influence of levodopa treatment
por: Kuric, Enida, et al.
Publicado: (2014)

Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers
por: Hose, Dorothea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_im84g2gbg4ucm2rdgv1rdckj80